Piotr Jarosz

Piotr Jarosz

Auto-generated profile, based on publicly available information

Piotr Jarosz

Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Computer Methods in Materials Science
Verified
Journal Article
Open access
PJPiotr Jarosz
Piotr Jarosz
JTJolanta Talar
Jolanta Talar
JKJan Kusiak
Jan Kusiak
The paper presents an attempt of the exploration of data sets collected in the copper flash smelting process. The goal of the research was to find the association rules occurring between selected output parameters of the process – copper concentration in the slag and lead concentration in blister copper – and input process parameters. The discovered relationships extend the knowledge on the process and can help to improve the models describing the flash smelting process and the process control system algorithms.

28 December 2020 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
MKMaciej Kamieniak
Maciej Kamieniak
NWNatalia Wolanin
Natalia Wolanin
PJPiotr Jarosz
Piotr Jarosz
IKIzabela Kobiałka
Izabela Kobiałka
KKKamil Kośmider
Kamil Kośmider
Konrad RejdakKonrad Rejdak
Konrad Rejdak

21 December 2020 in Medycyna Ogólna i Nauki o Zdrowiu
Verified
Journal Article
Open access
NWNatalia Wolanin
Natalia Wolanin
MKMaciej Kamieniak
Maciej Kamieniak
PJPiotr Jarosz
Piotr Jarosz
IKIzabela Kobiałka
Izabela Kobiałka
KKKamil Kośmider
Kamil Kośmider
Konrad RejdakKonrad Rejdak
Konrad Rejdak
Introduction and objective: Multiple sclerosis (MS) is the most common demyelinating disease. The symptoms resulting from the destruction of the myelin sheaths in the CNS are very diverse. The cause of the disease is not fully understood. Treatment can be divided into symptomatic, relapse...

26 August 2022 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MMMagdalena Marzęda
Magdalena Marzęda
TSTomasz Swatko
Tomasz Swatko
ABAgnieszka Blicharz
Agnieszka Blicharz
TSTomasz Stachura
Tomasz Stachura
MKMaciej Kamieniak
Maciej Kamieniak
IKIzabela Kobiałka
Izabela Kobiałka
Introduction and purpose: Migraine is a chronic condition affecting up to 10% of the adult population in Poland. Migraine pain is severe and may be accompanied by nausea or vomiting, as well as hypersensitivity to light, sounds or smells. Chronic form of migraine means the occurrence of headache a minimum of 15 days per month, for a period of at least three months, of which eight days or more of pain meet the criteria for migraine pain. The chronic form of migraine is targeted for treatment with botulinum toxin, a neurotoxin secreted by the bacteria Clostridium botulinum. Brief description of the state of knowledge: The pathogenesis of migraine is still unknown. There are many hypotheses explaining the origin of migraine pain, of which the most plausible seems to be the theory involving the trigeminal nerve system, as well as trigger points in the head and neck area. Their activation leads to the triggering of pain. Botulinum toxin has been used to treat migraine for several years. The only registered drug is Botox, the effectiveness of which has been confirmed in clinical studies. The preparation is administered by injection into the muscles of the head and neck region in cycles with an interval of 12 weeks. Botulinum toxin works by blocking the release of inflammatory and pain mediators from the trigeminal nerve endings. Summary: Chronic migraine refers to the occurrence of headache for more than half of the month, which significantly reduces the quality of life of people worldwide. Migraine headaches often refractory to pharmacological treatment may respond well to botulinum toxin type A. Therapy should be under the supervision of a neurologist, who will familiarise the patient with the expected effects of botulinum toxin treatment before starting treatment.

26 August 2022 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MKMaciej Kamieniak
Maciej Kamieniak
NWNatalia Wolanin
Natalia Wolanin
MMMagdalena Marzęda
Magdalena Marzęda
PJPiotr Jarosz
Piotr Jarosz
IKIzabela Kobiałka
Izabela Kobiałka
TSTomasz Swatko
Tomasz Swatko
Along with the increasing number of reported cases, multiple sclerosis, one of the main causes of disability among young adults, is nowadays an increasingly common health problem. Considering the fact that it occurs mainly between 20 and 40 years and affects women more often, the question of the impact of the disease on pregnancy becomes obvious. In view of the wide selection of drugs for various purposes and often highly individualized forms of therapy, it seems also important to determine the safety profile of these agents in relation to the health of the pregnant woman and the fetus. All of this is a significant challenge for neurologists and obstetricians and is the subject of many research and studies. The awareness of society, especially women, in the face of the growing problem seems to be equally important. This paper summarizes the current state of knowledge on these issues.

31 March 2020 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
NWNatalia Wolanin
Natalia Wolanin
MKMaciej Kamieniak
Maciej Kamieniak
KKKamil Kośmider
Kamil Kośmider
PJPiotr Jarosz
Piotr Jarosz
MBMichał Borys
Michał Borys
Introduction: Acute respiratory distress syndrome is an inflammatory process that results in impaired lung function. It is predicted that by 2025, it will be the third largest cause of death. In some cases, extracorporeal membrane oxygenation may be the last option, improving patient outcome....